The DOI matches its Crossref record; 248 of the 248 references it cites were found in a registry or an index.
Neuroinflammatory Markers: Key Indicators in the Pathology of Neurodegenerative Diseases
Open accessAbstract
Neuroinflammation, a protective response of the central nervous system (CNS), is associated with the pathogenesis of neurodegenerative diseases. The CNS is composed of neurons and glial cells consisting of microglia, oligodendrocytes, and astrocytes. Entry of any foreign pathogen activates the glial cells (astrocytes and microglia) and overactivation of these cells triggers the release of various neuroinflammatory markers (NMs), such as the tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-1β (IL-10), nitric oxide (NO), and cyclooxygenase-2 (COX-2), among others. Various studies have shown the role of neuroinflammatory markers in the occurrence, diagnosis, and treatment of neurodegenerative diseases. These markers also trigger the formation of various other factors responsible for causing several neuronal diseases including Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), multiple sclerosis (MS), ischemia, and several others. This comprehensive review aims to reveal the mechanism of neuroinflammatory markers (NMs), which could cause different neurodegenerative disorders. Important NMs may represent pathophysiologic processes leading to the generation of neurodegenerative diseases. In addition, various molecular alterations related to neurodegenerative diseases are discussed. Identifying these NMs may assist in the early diagnosis and detection of therapeutic targets for treating various neurodegenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–248 of 248
Lanzillo, R., Orefice, G., Quarantelli, M., Rinaldi, C., Prinster, A., Ventrella, G., Spitaleri, D. L. A., Lus, G., Vacca, G., Carotenuto, B., et al. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458509358909 · Cited by 83
Purinergic contribution to amyotrophic lateral sclerosis
Volonté, C., Apolloni, S., Parisi, C., & Amadio, S. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.026 · Cited by 80
Enhanced expression of fractalkine in HIV-1 associated dementia
Pereira, C. F., Middel, J., Jansen, G. H., Verhoef, J., & Nottet, H. S. L. M. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00262-4 · Cited by 78
Hughes, C., Ward, M., Tracey, F., Hoey, L., Molloy, A. M., Pentieva, K. D., & McNulty, H. (2017) · Nutrients · doi:10.3390/nu9010053 · Cited by 78
Endangered species mitochondrial DNA loss as a mechanism of human disease
Gilkerson, R. (2011) · Frontiers in Bioscience-Scholar · doi:10.2741/428 · Cited by 77
Ramesh, G., Benge, S., Pahar, B., & Philipp, M. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-72 · Cited by 76
Role of Peripheral Immune Cells-Mediated Inflammation on the Process of Neurodegenerative Diseases
Yang, Q., Wang, G., & Zhang, F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.582825 · Cited by 74
Peripheral and Central Nervous System Immune Response Crosstalk in Amyotrophic Lateral Sclerosis
Liu, Z., Cheng, X., Zhong, S., Zhang, X., Liu, C., Liu, F., & Zhao, C. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00575 · Cited by 73
Toward Understanding the Molecular Pathology of Huntington's Disease
Wellington, C. L., Brinkman, R. R., OʼKusky, J. R., & Hayden, M. R. (1997) · Brain Pathology · doi:10.1111/j.1750-3639.1997.tb00897.x · Cited by 72
Felton, L. M., Cunningham, C. M., Rankine, E. L., Waters, S., Boche, D., & Perry, V. H. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.03.008 · Cited by 70
Yu, Z., & Kone, B. C. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000114556.19556.f9 · Cited by 70
Willenborg, D. O., Staykova, M. A., Fordham, S., O’Brien, N. C., & Liñares, D. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.09.007 · Cited by 67
NF-κB and STAT3 signaling hubs for lung innate immunity
Quinton, L. J., & Mizgerd, J. P. (2011) · Cell and Tissue Research · doi:10.1007/s00441-010-1044-y · Cited by 65
Protein aggregation, misfolding and consequential human neurodegenerative diseases
Sami, N., Rahman, S., Kumar, V., Zaidi, S., Islam, A., Ali, S., Ahmad, F., & Hassan, M. I. (2017) · International Journal of Neuroscience · doi:10.1080/00207454.2017.1286339 · Cited by 64
Carroll, J. A., Striebel, J. F., Race, B., Phillips, K., & Chesebro, B. (2015) · Journal of Virology · doi:10.1128/jvi.02952-14 · Cited by 63
Peng, H., Li, H., Sheehy, A. M., Cullen, P. F., Allaire, N., & Scannevin, R. H. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.08.006 · Cited by 63
Microglia in Alzheimer Brain: A Neuropathological Perspective
Mrak, R. E. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/165021 · Cited by 63
Statin use and risk of Parkinson’s disease: a meta-analysis of observational studies
Undela, K., Gudala, K., Malla, S., & Bansal, D. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6606-3 · Cited by 62
Memantine and Kynurenic Acid: Current Neuropharmacological Aspects
Majláth, Z., Török, N., Toldi, J., & Vécsei, L. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666151113123221 · Cited by 59
Alzheimer's Disease: Emerging Trends in Small Molecule Therapies
Mohamed, T., & Rao, P. P. N. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711797200435 · Cited by 58
Accelerated prion disease pathogenesis in toll-like receptor 4 signaling-mutant mice.
Spinner, D. S., Cho, I. S., Park, S. Y., Kim, J. I., Meeker, H. C., Ye, X., LaFauci, G., Kerr, D. J., Flory, M. J., Kim, B. S., et al. (2008) · Journal of Virology · doi:10.1128/jvi.00522-08 · Cited by 57
Cunningham, C. M., Wilcockson, D. C., Boche, D., & Perry, V. H. (2005) · Journal of Virology · doi:10.1128/jvi.79.8.5174-5184.2005 · Cited by 55
Thornton, P., Pinteaux, E., Allan, S. M., & Rothwell, N. J. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.09.002 · Cited by 53
Soluble cell adhesion molecules in monocytes of Alzheimer’s disease and mild cognitive impairment
Hochstrasser, T., Weiss, E. M., Marksteiner, J., & Humpel, C. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.10.005 · Cited by 52
Neuroprotection for Huntington’s Disease: Ready, Set, Slow
Hersch, S. M., & Rosas, H. D. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.01.003 · Cited by 52
Gargiulo, S., Anzilotti, S., Coda, A. R. D., Gramanzini, M., Greco, A., Panico, M., Vinciguerra, A., Zannetti, A., Vicidomini, C., Dollé, F., et al. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3311-y · Cited by 52
Rossi, F., Miggiano, R., Ferraris, D. M., & Rizzi, M. (2019) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00007 · Cited by 52
Integrated Pathways of COX-2 and mTOR: Roles in Cell Sensing and Alzheimer’s Disease
Tyagi, A., Kamal, M. A., & Poddar, N. K. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00693 · Cited by 50
Zhao, Y., Xin, Y., He, Z., & Hu, W. (2018) · Neural Plasticity · doi:10.1155/2018/6323901 · Cited by 49
Reciprocal influence of connexins and apical junction proteins on their expressions and functions
Derangeon, M., Spray, D. C., Bourmeyster, N., Sarrouilhe, D., & Hervé, J. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.10.023 · Cited by 45
Accelerated Prion Replication in, but Prolonged Survival Times of, Prion-Infected CXCR3−/−Mice
Riemer, C., Schultz, J., Burwinkel, M., Schwarz, A., Mok, S. W. F., Gültner, S., Bamme, T., Norley, S., van Landeghem, F., Lu, B., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01371-08 · Cited by 45
Clark, I. A., & Vissel, B. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14471 · Cited by 45
Apo-E4 Allele in Conjunction with Aβ42 and Tau in CSF: Biomarker for Alzheimers Disease
Kandimalla, R. J. L., Prabhakar, S., Binukumar, B. K., Wani, W. Y., Gupta, N., Sharma, D. R., Sunkaria, A., Grover, V., Bhardwaj, N., Jain, K., et al. (1970) · Current Alzheimer Research · doi:10.2174/156720511795256071 · Cited by 43
Crespo, I., Roomp, K., Jurkowski, W., Kitano, H., & del Sol, A. (2012) · BMC Systems Biology · doi:10.1186/1752-0509-6-132 · Cited by 42
Tribouillard‐Tanvier, D., Race, B., Striebel, J. F., Carroll, J. A., Phillips, K. L., & Chesebro, B. W. (2012) · Journal of Virology · doi:10.1128/jvi.01340-12 · Cited by 37
Statins in Neurological Disorders: Mechanisms and Therapeutic Value
Reiss, A. B., & Wirkowski, E. J. (2009) · The Scientific World JOURNAL · doi:10.1100/tsw.2009.141 · Cited by 37
Bindarit, Inhibitor of CCL2 Synthesis, Protects Neurons Against Amyloid-β-Induced Toxicity
Severini, C., Passeri, P. P., Ciotti, M. T., Florenzano, F., Possenti, R., Zona, C., Matteo, A. D., Guglielmotti, A., Calissano, P., Pachter, J. S., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-131070 · Cited by 36
Liu, T., Guo, F., Zhu, X., He, X., & Xie, L. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5209 · Cited by 36
Zhao, L., Chen, T., Wang, C., Li, G., Zhi, W., Yin, J., Wan, Q., & Chen, L. (2016) · BMC Neurology · doi:10.1186/s12883-016-0533-3 · Cited by 34
Kandimalla, R. J. L., Prabhakar, S., Binukumar, B. K., Wani, W. Y., Sharma, D. R., Grover, V., Bhardwaj, N., Jain, K., & Gill, K. D. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.06.075 · Cited by 28
Presence of an acute phase response in sheep with clinical classical scrapie
Meling, S., Bårdsen, K., & Ulvund, M. J. (2012) · BMC Veterinary Research · doi:10.1186/1746-6148-8-113 · Cited by 26
Carroll, J. A., Race, B., Phillips, K. L., Striebel, J. F., & Chesebro, B. W. (2017) · Journal of General Virology · doi:10.1099/jgv.0.000876 · Cited by 26
Kwon, H. S., Lee, E.-H., Park, H.-H., Jin, J.-H., Choi, H., Lee, K., Lee, Y. J., Lee, J., de Oliveira, F. M. S., Kim, H. Y., et al. (2020) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2020.02.016 · Cited by 26
Investigation ofMcp1as a Quantitative Trait Gene for Prion Disease Incubation Time in Mouse
O’Shea, M. F., Maytham, E. G., Linehan, J., Brandner, S., Collinge, J., & Lloyd, S. E. (2008) · Genetics · doi:10.1534/genetics.108.090894 · Cited by 23
Monocyte recruitment into the scrapie-affected brain
Williams, A. E., Ryder, S., & Blakemore, W. F. (1995) · Acta Neuropathologica · doi:10.1007/bf00294316 · Cited by 23
Mizrahi, K., & Askenasy, N. (2014) · Blood · doi:10.1182/blood-2014-03-559641 · Cited by 23
The Effects of Immune System Modulation on Prion Disease Susceptibility and Pathogenesis
Mabbott, N. A., Bradford, B. M., Pal, R., Young, R. A., & Donaldson, D. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197299 · Cited by 22
Potential anti-neuroinflammatory compounds from Australian plants – A review
Singh, A., Raju, R., & Münch, G. W. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104897 · Cited by 11
Cited by
Multifunctional nanoparticle-mediated combining therapy for human diseases
Li, X., Peng, X., Zoulikha, M., Boafo, G. F., Magar, K. T., Ju, Y., & He, W. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01668-1 · Cited by 521
Alzheimer’s Disease: Exploring the Landscape of Cognitive Decline
Tenchov, R., Sasso, J. M., & Zhou, Q. A. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00339 · Cited by 170
Sharma, R., Singla, R. K., Banerjee, S., Sinha, B., Shen, B., & Sharma, R. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104795 · Cited by 81
Broos, J. Y., van der Burgt, R. T. M., Konings, J., Rijnsburger, M., Werz, O., de Vries, H. E., Giera, M., & Kooij, G. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02981-w · Cited by 41
Metadata
- Authors
- Rauf, A., Badoni, H., Abu-Izneid, T., Olatunde, A., Rahman, M. M., Painuli, S., Semwal, P., Wilairatana, P., & Mubarak, M. S.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2022-05-17
- Volume
- 27
- Issue
- 10
- Pages
- 3194
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W4280565855
- Cited by
- 306
- References
- 248
- FWCI
- 18.15
- Type
- journal article
- Language
- en
- Status
- Retracted
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.